A Service For Professionals Sunday, December 17, 2017
Contact (202) 540-8337
Company News Today
A Service For Professionals Sunday, December 17, 2017 11610 Sources 421,780,842 Articles 2,875,095 Readers
Contact (202) 540-8337

Healthcare: Arthrex, Kensey Nash Enter Marketing, Distribution Agreement

June 28, 2010 (FinancialWire) – Medical device maker Kensey Nash Corp. (NASDAQ: KNSY) and Arthrex, Inc., a firm providing sports medicine product development and educational services for orthopaedic surgeons, have inked an agreement regarding products developed from Kensey Nash's extracellular matrix technology.

The agreement is based upon Kensey Nash's proprietary tissue processing technology, known as the Optrix process, which gently disinfects tissues, inactivates viruses and removes cells while preserving extracellular matrix components.  

Under the agreement, Kensey Nash will develop and manufacture porcine dermis derived biologic surgical meshes, which Arthrex will market and distribute for use in sports medicine tendon repair procedures and small joint surgeries.

ECM products can be used in a range of surgical procedures, including sports medicine, for the reinforcement and repair of soft tissue.  

Specific terms of the agreement were not disclosed.

Pennsylvania-based Kensey Nash is a medical device company primarily focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technology.  

Florida-based Arthrex has developed more than 5,000 products for arthroscopic and minimally invasive orthopaedic surgical procedures.

Real-time, streaming research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at http://investrend.stocksmart.com/ss/html/hpcompany.html). Current valuation analysis research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at http://www.valuengine.com/rep/searchsrep?pid=42&srchfor=).

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public other companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (at http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation from subject entities, companies, equities, or representatives thereof, for its news, opinions or distributions. Further disclosure is posted at the FinancialWire(tm) website (at http://www.financialwire.net/disclosures.php and http://www.financialwire.net/2010/04/23/safe-harbor/). Additional resources for investors are also accessible via the FinancialWire(tm) website (at http://www.financialwire.net/2010/04/23/investor-resources/). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Copyright © MMX, FinancialWire(tm); All rights reserved.

[hlmsmlh] [hlthcrdp] [nwdlsldw] [hlthcrdp] [tchnlgy] [btnwswntb]

Powered by EIN Presswire